2026. Characterisation of mutations in cytogenetically normal acute myeloid leukaemia patients with triple-negative FLT3-ITD/ NPM1/CEBPA subgroup using targeted next-generation sequencing. International Medical Research Journal. 11, 1 (Sep. 2026). DOI:https://doi.org/10.63719/imrj.2025.11.01.003.